Erik Jensen is a neonatologist and clinician-scientist. His research seeks to improve the long-term respiratory health of premature infants through: (1) clinical and translational studies that aim to develop evidence-based strategies to prevent and treat BPD; (2) novel characterization of disease severity and phenotypes in BPD; and (3) application of health services research techniques to investigate the association between care practices and hospital-level factors and neonatal morbidity and mortality.

Dr. Jensen’s research is supported by grant funding from the National Heart Lung and Blood Institute (NHLBI), the National Institute of Child Health and Human Development (NICHD), and the American Lung Association (ALA). He is a member of the International BPD Collaborative and the International Neonatal Consortium (INC) BPD working group.